All drugs.

Search drugs by brand or generic name, or refine the directory by prescription status, class, indication, manufacturer, and specialty.

Advertisement

Enter at least 3 characters to search the full directory.

Results

Showing 1–25 of 30 drugs · filtered

BYETTA (exenatide)

INCRETIN MIMETIC/GLP-1 AND DUAL GIP/GLP-1 RECEPTOR AGONIST · TYPE 2 DIABETES MELLITUS
AstraZeneca Pharmaceuticals

TRULICITY (dulaglutide)

INCRETIN MIMETIC/GLP-1 AND DUAL GIP/GLP-1 RECEPTOR AGONIST · TYPE 2 DIABETES MELLITUS ·+1
Eli Lilly and Company

SAXENDA (liraglutide)

DIET AIDS · WEIGHT LOSS MANAGEMENT FOR OBESE PATIENT (BODY MASS INDEX 30 OR GREATER) ·+1
NOVO NORDISK

OZEMPIC (semaglutide)

INCRETIN MIMETIC/GLP-1 AND DUAL GIP/GLP-1 RECEPTOR AGONIST · TYPE 2 DIABETES MELLITUS ·+2
NOVO NORDISK

RYBELSUS (semaglutide)

INCRETIN MIMETIC/GLP-1 AND DUAL GIP/GLP-1 RECEPTOR AGONIST · TYPE 2 DIABETES MELLITUS ·+1
NOVO NORDISK

WEGOVY (semaglutide)

DIET AIDS · WEIGHT LOSS MANAGEMENT FOR OBESE PATIENT (BODY MASS INDEX 30 OR GREATER) ·+3
NOVO NORDISK

MOUNJARO (tirzepatide)

INCRETIN MIMETIC/GLP-1 AND DUAL GIP/GLP-1 RECEPTOR AGONIST · TYPE 2 DIABETES MELLITUS ·+1
Eli Lilly and Company

LIRAGLUTIDE

DIET AIDS · TYPE 2 DIABETES MELLITUS
TEVA PHARM

LIRAGLUTIDE

INCRETIN MIMETIC/GLP-1 AND DUAL GIP/GLP-1 RECEPTOR AGONIST · TYPE 2 DIABETES MELLITUS
A-S MEDICATION

OZEMPIC (semaglutide)

INCRETIN MIMETIC/GLP-1 AND DUAL GIP/GLP-1 RECEPTOR AGONIST · TYPE 2 DIABETES MELLITUS ·+2
A-S MEDICATION

TRULICITY (dulaglutide)

INCRETIN MIMETIC/GLP-1 AND DUAL GIP/GLP-1 RECEPTOR AGONIST · TYPE 2 DIABETES MELLITUS ·+1
A-S MEDICATION

WEGOVY (semaglutide)

DIET AIDS · WEIGHT LOSS MANAGEMENT FOR OBESE PATIENT (BODY MASS INDEX 30 OR GREATER) ·+3
A-S MEDICATION

LIRAGLUTIDE

INCRETIN MIMETIC/GLP-1 AND DUAL GIP/GLP-1 RECEPTOR AGONIST · TYPE 2 DIABETES MELLITUS
Hikma Pharmaceuticals USA

LIRAGLUTIDE

INCRETIN MIMETIC/GLP-1 AND DUAL GIP/GLP-1 RECEPTOR AGONIST · TYPE 2 DIABETES MELLITUS
MEITHEAL PHARMA

LIRAGLUTIDE

DIET AIDS · TYPE 2 DIABETES MELLITUS
CIPLA USA, INC.